Cargando…
A labelling system improves parental comfort and willingness to use topical corticosteroids for paediatric atopic dermatitis
OBJECTIVES: In the United Kingdom, atopic dermatitis (AD) affects 20% of children and topical corticosteroids (TCS) are a mainstay of AD treatment regimes. Many TCS have similar packaging despite significant differences in potency frequently leading to confusion, and along with misinformation and st...
Autores principales: | Wilson, F., Harnik, E., Gore, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060095/ https://www.ncbi.nlm.nih.gov/pubmed/35664821 http://dx.doi.org/10.1002/ski2.11 |
Ejemplares similares
-
Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey
por: El Hachem, Maya, et al.
Publicado: (2017) -
Addressing topical corticosteroid phobia in atopic dermatitis: The
role of the pharmacist
por: Ladda, Matthew, et al.
Publicado: (2021) -
TOPICOP©: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents
por: Moret, Leïla, et al.
Publicado: (2013) -
Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study
por: Albogami, Maha Fayez, et al.
Publicado: (2023) -
Effect of Paediatric Atopic Dermatitis on Parental Sleep Quality
por: FORER, Ester, et al.
Publicado: (2023)